妊娠高血圧学会では以下のような研究・報告をおこなっています。

• 妊娠中の家庭血圧についてー我が国の多施設前方視的研究―
  　Y. Suzuki Hypertension research 2022,45(10):1563-1574
  　妊娠中の家庭血圧について　論文日本語要約
  　家庭血圧を用いた妊娠週数毎の高血圧の基準値
• 妊娠高血圧症候群 早発型・遅発型の発症週数についての検討
  Exponential increase of the gestational-age-specific incidence of preeclampsia onset (COPE study): a multicenter retrospective cohort study in women with maternal check-ups at <20 weeks of gestation in Japan
  　A. Ohkuchi Hypertension Research 2022:45:1679-1689
• 早発型妊娠高血圧腎症/妊娠高血圧母体から出生した児の３歳時発達指数への影響
  Early-onset preeclampsia/gestational hypertension may be associated with a low incidence of cerebral palsy at 3 years old in singleton very low-birth-weight infants born at 28–31 weeks of gestation (EOPE-DQ study): a multi-center retrospective cohort study in 2013–2016
  　A.Ohkuchi Hypertension Research (2025) 48:88–101
• 我が国の妊婦の血圧測定とその評価に関する実態調査
  A survey on the measurement of blood pressure in pregnant women and management of hypertensive disorders of pregnancy by the Japan Society for the Study of Hypertension in Pregnancy (JSSHP)
  　H.Suzuki Hypertension Research in Pregnancy 2021; 9: 30–39
• 高血圧・白衣高血圧・仮面高血圧妊婦の妊娠高血圧・妊娠高血圧腎症の有病率：多施設コホート研究
  Prevalence of chronic hypertension and white coat hypertension in women presenting with at least one hypertension level on two to three consecutive measurements in a clinical setting at <20 weeks of gestation (JP-WCH1 study): A multicenter prospective cohort study
  　C.Hirashima Hypertension Research in Pregnancy 2022: 10:101-107
• 妊娠高血圧症候群の胎児発育不全・子宮胎盤機能不全の診断と管理に関する全国調査
  Diagnosis and management of fetal growth restriction and uteroplacental dysfunction in hypertensive disorders of pregnancy in Japan: a nationwide survey by the Japan Society for the Study of Hypertension in Pregnancy (JSSHP)
  　K.Mimura Hypertension Research in Pregnancy 2022; 10: 8–18
• 妊婦に特化した高血圧の基準策定のための検討 -文献レビュー及びメタ解析-
  Maternal and perinatal outcomes according to blood pressure levels for prehypertension: A review and meta-analysis
  　H. Suzuki Hypertension research in Pregnancy 2022; 10: 29–39

• 随時尿蛋白/クレアチニン比による母児の予後調査（論文投稿中）
• 産後蛋白尿の判定基準の設定：多機関協働前向きコホート研究（結果解析中）
• 妊娠高血圧症候群における臓器障害、子宮胎盤機能不全（特に血小板と胎児発育不全）と母時予後、PE/GHの発症率の変化 多施設共同後向きコホート研究